As of close of business last night, Healthpeak Properties Inc.’s stock clocked out at 24.55, up 0.45% from its previous closing price of $24.44. In other words, the price has increased by $+0.11 from its previous closing price. On the day, 3653126 shares were traded. PEAK reached its highest trading level at $24.71 during the session, while it also had its lowest trading level at $24.04.
To gain a deeper understanding of PEAK’s stock, we examine its different ratios. In the meantime, Its Debt-to-Equity ratio is 1.02 whereas as Long-Term Debt/Eq ratio is at 1.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Citigroup on July 08, 2022, Upgraded its rating to Buy and sets its target price to $31 from $33 previously.
On June 03, 2022, CapitalOne started tracking the stock assigning a Equal Weight rating and target price of $34.
BofA Securities Downgraded its Buy to Neutral on May 19, 2022, while the target price for the stock was maintained at $32.
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 19 when GARVEY CHRISTINE sold 300 shares for $34.35 per share. The transaction valued at 10,306 led to the insider holds 22,709 shares of the business.
As of this moment, Healthpeak’s Price-to-Earnings (P/E) ratio for their current fiscal year is 62.15, and their Forward P/E ratio for the next fiscal year is 54.07. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.68 while its Price-to-Book (P/B) ratio in mrq is 2.10.
Stock Price History:
Over the past 52 weeks, PEAK has reached a high of $36.85, while it has fallen to a 52-week low of $23.23. The 50-Day Moving Average of the stock is 26.81, while the 200-Day Moving Average is calculated to be 30.74.
It appears that PEAK traded 3.73M shares on average per day over the past three months and 3.82M shares per day over the past ten days. A total of 539.56M shares are outstanding, with a floating share count of 538.00M. Insiders hold about 0.10% of the company’s shares, while institutions hold 99.40% stake in the company. Shares short for PEAK as of Jul 14, 2022 were 9.49M with a Short Ratio of 2.53, compared to 9.08M on Jun 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 1.76% and a Short% of Float of 2.92%.
Dividends & Splits
With its trailing 12-month dividend rate of 1.27, PEAK has a forward annual dividend rate of 1.20. Against a Trailing Annual Dividend Yield of 5.20%, it implies a Forward Annual Dividend Yield of 4.34%. The stock’s 5-year Average Dividend Yield is 4.84. The current Payout Ratio is 293.30% for PEAK, which recently paid a dividend on Aug 18, 2022 with an ex-dividend date of Aug 04, 2022. Stock splits for the company last occurred on Oct 31, 2016 when the company split stock in a 1098:1000 ratio.
As of right now, 9 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of $0.1 for the current quarter, with a high estimate of $0.15 and a low estimate of $0.08, while EPS last year was $0.51. The consensus estimate for the next quarter is $0.1, with high estimates of $0.14 and low estimates of $0.07.
Analysts are recommending an EPS of between $0.55 and $0.3 for the fiscal current year, implying an average EPS of $0.43. EPS for the following year is $0.47, with 11 analysts recommending between $0.54 and $0.35.
A total of 11 analysts have provided revenue estimates for PEAK’s current fiscal year. The highest revenue estimate was $2.1B, while the lowest revenue estimate was $1.92B, resulting in an average revenue estimate of $2.02B. In the same quarter a year ago, actual revenue was $1.9B, up 6.70% from the average estimate. Based on 11 analysts’ estimates, the company’s revenue will be $2.15B in the next fiscal year. The high estimate is $2.3B and the low estimate is $2.01B. The average revenue growth estimate for next year is up 6.40% from the average revenue estimate for this year.